Clinical predictors of early infarct-related artery patency following thrombolytic therapy: Importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: The GUSTO-I experience

被引:57
作者
Lundergan, CF
Reiner, JS
McCarthy, WF
Coyne, KS
Califf, RM
Ross, AM
机构
[1] George Washington Univ, Med Ctr, Cardiovasc Res Inst, Washington, DC 20037 USA
[2] George Washington Univ, GUSTO 1 Core Angiog Lab, Washington, DC 20037 USA
[3] Duke Univ, Durham, NC USA
关键词
D O I
10.1016/S0735-1097(98)00278-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The purpose of this study was to determine patient characteristics that are a priori predictors of early infarct related artery patency following thrombolytic therapy, and to provide a paradigm which may identify patients who would be most likely to achieve restoration of normal (TIMI 3) coronary flow in response to thrombolytic therapy. Background. Restoration of infarct-related artery perfusion in acute myocardial infarction is necessary for preservation of ventricular function and mortality reduction. Clinical variables that are a priori predictors of early patency with currently available thrombolytic regimens have not been fully characterized. Methods. The probability of early infarct-related artery patency (TIMI 3 flow) was determined by multivariable logistic regression. We determined a reduced (parsimonious) model for predicting early (90 min) infarct-related artery patency (TIMI grade 3) based on data from 1,030 patients in the GUSTO-I Angiographic study. Results. Predictors of 90 min TIMI 3 how are use of an accelerated t-PA regimen (vs. streptokinase containing regimens) (chi(2) = 39.1; p less than or equal to 0.0001), infarct related artery (RCA/Lcx vs. LAD) (chi(2) = 12.7; p = 0.0004), body weight (chi(2) = 10.3; p = 0.001) and history of smoking (chi(2) = 7.4; p = 0.007). Time from symptom onset to treatment was not significant (p = 0.71). Conclusions. The efficacy of currently available thrombolytic regimens is chiefly dependent on choice of thrombolytic regimen, body weight, infarct-related coronary artery and smoking history. Clinical variables alone correctly predict a priori TIMI 3 flow in the infarct-related artery 64% of the time. Patients with body weights greater than 85 kg are at a significant disadvantage with regard to achieving successful thrombolysis compared to those with lesser body weights. (J Am Coil Cardiol 1998;32:641-7) (C) 1998 by the American College of Cardiology.
引用
收藏
页码:641 / 647
页数:7
相关论文
共 28 条
  • [1] MULTICENTER REPERFUSION TRIAL OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) IN ACUTE MYOCARDIAL-INFARCTION - CONTROLLED COMPARISON WITH INTRACORONARY STREPTOKINASE
    ANDERSON, JL
    ROTHBARD, RL
    HACKWORTHY, RA
    SORENSEN, SG
    FITZPATRICK, PG
    DAHL, CF
    HAGAN, AD
    BROWNE, KF
    SYMKOVIAK, GP
    MENLOVE, RL
    BARRY, WH
    ECKERSON, HW
    MARDER, VJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) : 1153 - 1163
  • [2] MULTICENTER PATENCY TRIAL OF INTRAVENOUS ANISTREPLASE COMPARED WITH STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
    ANDERSON, JL
    SORENSEN, SG
    MORENO, FL
    HACKWORTHY, RA
    BROWNE, KF
    DALE, HT
    LEYA, F
    DANGOISSE, V
    ECKERSON, HW
    MARDER, VJ
    [J]. CIRCULATION, 1991, 83 (01) : 126 - 140
  • [3] [Anonymous], STAT METHODS
  • [4] EVALUATION OF PARADOXIC BENEFICIAL-EFFECTS OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - MECHANISM OF THE SMOKERS PARADOX FROM THE GUSTO-I TRIAL, WITH ANGIOGRAPHIC INSIGHTS
    BARBASH, GI
    REINER, J
    WHITE, HD
    WILCOX, RG
    ARMSTRONG, PW
    SADOWSKI, Z
    MORRIS, D
    AYLWARD, P
    WOODLIEF, LH
    TOPOL, EJ
    CALIFF, RM
    ROSS, AM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) : 1222 - 1229
  • [5] THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION (TAMI-1) TRIAL - INFLUENCE OF INFARCT LOCATION ON ARTERIAL PATENCY, LEFT-VENTRICULAR FUNCTION AND MORTALITY
    BATES, ER
    CALIFF, RM
    STACK, RS
    ARONSON, L
    GEORGE, BS
    CANDELA, RJ
    KEREIAKES, DJ
    ABBOTTSMITH, CW
    ANDERSON, L
    PITT, B
    ONEILL, WW
    TOPOL, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (01) : 12 - 18
  • [7] Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (Recombinant plasminogen activator) and front-loaded, accelerated alteplase (Recombinant tissue plasminogen activator) in patients with acute myocardial infarction
    Bode, C
    Smalling, RW
    Berg, G
    Burnett, C
    Lorch, G
    Kalbfleisch, JM
    Chernoff, R
    Christie, LG
    Feldman, RL
    Seals, AA
    Weaver, WD
    [J]. CIRCULATION, 1996, 94 (05) : 891 - 898
  • [8] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE
    CHESEBRO, JH
    KNATTERUD, G
    ROBERTS, R
    BORER, J
    COHEN, LS
    DALEN, J
    DODGE, HT
    FRANCIS, CK
    HILLIS, D
    LUDBROOK, P
    MARKIS, JE
    MUELLER, H
    PASSAMANI, ER
    POWERS, ER
    RAO, AK
    ROBERTSON, T
    ROSS, A
    RYAN, TJ
    SOBEL, BE
    WILLERSON, J
    WILLIAMS, DO
    ZARET, BL
    BRAUNWALD, E
    [J]. CIRCULATION, 1987, 76 (01) : 142 - 154
  • [9] Freund R.J., 1991, SAS SYSTEM REGRESSIO
  • [10] EFFECT OF CIGARETTE-SMOKING ON CORONARY PATENCY AFTER THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION
    GOMEZ, MA
    KARAGOUNIS, LA
    ALLEN, A
    ANDERSON, JL
    BROWNE, KF
    DANGOISSE, V
    LEYA, F
    LYONS, RM
    DALE, HT
    WATSON, LE
    SYMKOVIAK, GP
    FITZPATRICK, P
    HAGAN, AD
    CHRISTIE, LG
    MILLER, RH
    ASKINS, JC
    STRINGER, KA
    DAHL, CF
    HALL, SM
    ABRAMS, J
    MONRAD, ES
    BOVE, AA
    KOSINSKI, EJ
    MORCH, JE
    FALCONE, W
    BARRY, WH
    RATHBUN, JD
    SMITH, WB
    LACH, RD
    SINGH, JB
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05) : 373 - 378